Literature DB >> 15681573

Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials.

Pierfrancesco Agostoni1, Giuseppe G L Biondi-Zoccai, Gabriele L Gasparini, Maurizio Anselmi, Giorgio Morando, Marco Turri, Antonio Abbate, Eugene P McFadden, Corrado Vassanelli, Piero Zardini, Antonio Colombo, Patrick W Serruys.   

Abstract

AIMS: To compare, by meta-analytical techniques, the clinical impact of bare-metal stenting vs. balloon angioplasty for the treatment of lesions in small coronary arteries. METHODS AND
RESULTS: We included trials with random allocation and prospective comparison of angioplasty vs. stenting, reference vessel diameter<3 mm, and follow-up>or=6 months. Random effect odds ratios (OR) for death, myocardial infarction (MI), repeat revascularization (RR), and major adverse cardiac events (MACEs) were computed. In a pre-specified subgroup analysis, we compared stenting with optimal (post-procedural stenosis<20%) and suboptimal (>20%) angioplasty. Thirteen studies (4383 patients) were selected. No differences were found in terms of death and MI, while MACEs, mainly driven by RR, were significantly less common after stenting (17.6%) than after angioplasty (22.7%), OR 0.71 (0.57-0.90). Heterogeneity among trials was present. When considering only optimal angioplasty, MACE rates were homogeneously similar, 17.9 vs. 21.1%, OR 0.86 (0.66-1.11). If angioplasty were suboptimal, MACEs were significantly more common after angioplasty (24%) than after stenting (17.3%), OR 0.62 (0.44-0.88).
CONCLUSION: Stenting is superior to balloon angioplasty for the treatment of small vessels, in particular after suboptimal angioplasty. However, MACE and RR rates remain high after stenting, and the advantage of stent over angioplasty is moderate. An optimal balloon angioplasty strategy (with provisional stenting) may achieve results not inferior to routine stenting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681573     DOI: 10.1093/eurheartj/ehi116

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

Review 1.  Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study.

Authors:  Giuseppe G L Biondi-Zoccai; Marzia Lotrionte; Antonio Abbate; Luca Testa; Enrico Remigi; Francesco Burzotta; Marco Valgimigli; Enrico Romagnoli; Filippo Crea; Pierfrancesco Agostoni
Journal:  BMJ       Date:  2006-01-16

2.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.

Authors:  Martin Unverdorben; Franz X Kleber; Hubertus Heuer; Hans-Reiner Figulla; Christian Vallbracht; Matthias Leschke; Bodo Cremers; Stefan Hardt; Michael Buerke; Hanns Ackermann; Michael Boxberger; Ralf Degenhardt; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

Review 3.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

4.  Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease.

Authors:  Yader Sandoval; Emmanouil S Brilakis; Mariana Canoniero; Demetris Yannopoulos; Santiago Garcia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 5.  Secondary prevention of ischaemic cardiac events.

Authors:  Jane S Skinner; Angela Cooper
Journal:  BMJ Clin Evid       Date:  2011-08-30

6.  Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation.

Authors:  L Zhang; Q Huang; Y Zhang; J Liu; B Hong; Y Xu; W Zhao
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 7.  Small coronary vessel angioplasty: outcomes and technical considerations.

Authors:  Sudhir Rathore
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

8.  Perioperative handling of patients on antiplatelet therapy with need for surgery.

Authors:  Matteo Nicola Dario Di Minno; Domenico Prisco; Anna Lilia Ruocco; Pasquale Mastronardi; Salvatore Massa; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2009-06-16       Impact factor: 3.397

9.  Clinical and angiographic features of small vessel stenting in the drug-eluting stent era.

Authors:  Refat Jabara; Marc Gradman; Jack P Chen; Spencer B King; Radhika Gadesam; Nicolas A F Chronos
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

Review 10.  Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group.

Authors:  Franz X Kleber; Harald Rittger; Klaus Bonaventura; Uwe Zeymer; Jochen Wöhrle; Raban Jeger; Benny Levenson; Sven Möbius-Winkler; Leonhard Bruch; Dieter Fischer; Christian Hengstenberg; Tudor Pörner; Detlef Mathey; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2013-08-28       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.